PDF: call-to-action-prevent-skin-cancer
Sun exposure, family history guide risk assessment for melanoma screening NEW YORK — Several factors can help better define…
New therapies raise hope for a breakthrough in tackling cancer By Arthur Allen, (Feb 17, 2014) In the summer of 2012, a…
Encouraging Data: The combination of the BRAF inhibitor vemurafenib (Zelboraf) with the investigational MEK inhibitor cobimetinib (GDC-0973) demonstrated a 13.7-month median progression-free…
Immunotherapy for melanoma progresses with some interesting response patterns By: SHARON WORCESTER, Oncology Report Digital Network HOLLYWOOD, FLA. – Tremendous progress has…
Endurance Athletes at high risk for skin cancer and melanoma. Fall is marathon season! Whether you’re running in Death Valley (December 4),…
ASK THE EXPERT: What does a full-body exam entail? Laurie Jacobson, MD is a fellowship-trained Mohs surgeon and a member of the…
